{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T03:52:55Z","timestamp":1773978775256,"version":"3.50.1"},"reference-count":35,"publisher":"Japanese Society of Internal Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018]]},"DOI":"10.2169\/internalmedicine.9407-17","type":"journal-article","created":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T22:12:38Z","timestamp":1509487958000},"page":"751-755","source":"Crossref","is-referenced-by-count":11,"title":["Comparison of the Frequency of Angioedema Attack, before and during Pregnancy, in a Patient with Type I Hereditary Angioedema"],"prefix":"10.2169","volume":"57","author":[{"given":"Atsushi","family":"Satomura","sequence":"first","affiliation":[{"name":"Division of Laboratory Medicine, Department of Pathology and Microbiology, Nihon University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Fujita","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Hypertension and Endocrinology, Department of Medicine, Nihon University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Division of Laboratory Medicine, Department of Pathology and Microbiology, Nihon University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Quincke HI. \u00dcber akutes umschriebenes Haut\u00f6dem. Monatsh Prakt Dermatol 1: 129-131, 1882."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Osler W. Hereditary angioneurotic edema. Am J Med Sci 95: 362-367, 1888.","DOI":"10.1097\/00000441-188804000-00004"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Cicardi M, Agostoni A. Hereditary angioedema. N Engl J Med 334: 1666-1667, 1996.","DOI":"10.1056\/NEJM199606203342510"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Craig T, Ayg\u00f6ren-P\u00fcrs\u00fcn E, Bork K, et al. WAO guideline for the management of hereditary angioedema. World Allergy Organ J 5: 182-199, 2012.","DOI":"10.1097\/WOX.0b013e318279affa"},{"key":"5","unstructured":"5. Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med 119: 267-274, 2006."},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Bork K, Barnstedt SE, Koch P, Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 356: 213-217, 2000.","DOI":"10.1016\/S0140-6736(00)02483-1"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Binkley KE, Davis A 3rd. Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. J Allergy Clin Immunol 106: 546-550, 2000.","DOI":"10.1067\/mai.2000.108106"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Bork K. Hereditary angioedema with normal C1 inhibition. Curr Allergy Asthma Rep 9: 280-285, 2009.","DOI":"10.1007\/s11882-009-0039-9"},{"key":"9","unstructured":"9. Bowen T, Cicardi M, Farkas H, et al. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol 6: 24, 2010."},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Cicardi M, Aberer W, Banerji A, et al. HAWK under the patronage of EAACI (European Academy of Allergy and Clinical Immunology). Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy 69: 602-616, 2014.","DOI":"10.1111\/all.12380"},{"key":"11","unstructured":"11. Vitrat-Hincky V, Gompel A, Dumestre-Perard C, et al. Type III hereditary angio-oedema: clinical and biological features in a French cohort. Allergy 65: 1331-1336, 2010."},{"key":"12","unstructured":"12. Craig TJ, Bernstein JA, Farkas H, Bouillet L, Boccon-Gibod I. Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting. Int Arch Allergy Immunol 165: 119-127, 2014."},{"key":"13","unstructured":"13. Czaller I, Visy B, Csuka D, et al. The natural history of hereditary angioedema and the impact of treatment with human C1-inhibitor concentrate during pregnancy: a long-term survey. Eur J Obstet Gynecol Reprod Biol 152: 44-49, 2010."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Gonz\u00e1lez-Quevedo T, Larco JI, Marcos C, et al. Management of pregnancy and delivery in patients with hereditary angioedema due to C1 inhibitor deficiency. J Investig Allergol Clin Immunol 26: 161-167, 2016.","DOI":"10.18176\/jiaci.0037"},{"key":"15","unstructured":"15. Caballero T, Canabal J, Rivero-Paparoni D, Caba\u00f1as R. Management of hereditary angioedema in pregnant women: a review. Int J Womens Health 6: 839-848, 2014."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Caballero T, Farkas H, Bouillet L, et al. C-1-INH Deficiency Working Group. International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency. J Allergy Clin Immunol 129: 308-320, 2012.","DOI":"10.1016\/j.jaci.2011.11.025"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Bork K, Fischer B, Dewald G. Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. Am J Med 114: 294-298, 2003.","DOI":"10.1016\/S0002-9343(02)01526-7"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Yip J, Cunliffe WJ. Hormonally exacerbated hereditary angioedema. Australas J Dermatol 33: 35-38, 1992.","DOI":"10.1111\/j.1440-0960.1992.tb00050.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Bouillet L, Longhurst H, Boccon-Gibod I, et al. Disease expression in women with hereditary angioedema. Am J Obstet Gynecol 199: e1-e4, 2008.","DOI":"10.1016\/j.ajog.2008.04.034"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Borradori L, Marie O, Rybojad M, et al. Hereditary angioedema and oral contraception. Dermatologica 181: 78-79, 1990.","DOI":"10.1159\/000247874"},{"key":"21","unstructured":"21. Hermans C. Successful management with C1-inhibitor concentrate of hereditary angioedema attacks during two successive pregnancies: a case report. Arch Gynecol Obstet 276: 271-276, 2007."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Caballero T, Sala-Cunill A, Cancian M, et al. Current status of implementation of self-administration training in various regions of Europe, Canada and the USA in the management of hereditary angioedema. Int Arch Allergy Immunol 161 (Suppl 1): 10-16, 2013.","DOI":"10.1159\/000351233"},{"key":"23","unstructured":"23. CSL Behring: CSL Behring Receives European Health Authorities&apos; Approval for Self-Administration of Berinert<sup>\u00ae<\/sup> [Internet]. 2011 [cited 2017 Feb. 8]. Available from: https:\/\/www.ots.at\/presseaussendung\/OTE_20110825_OTE0010\/csl-behring-receives-european-health-authorities-approval-for-self-administration-of-berinert"},{"key":"24","unstructured":"24. CSL Behring Receives FDA Approval of Expanded Label on Berinert<sup>\u00ae<\/sup> for Self-administration and Treatment of Acute Laryngeal Attacks of Hereditary Angioedema. CSL Behring Newsroom: News Archives 2012 [Internet]. [cited 2017 Feb. 8]. Available from: https:\/\/www.cslbehring.com\/vita\/newsroom"},{"key":"25","unstructured":"25. ViroPharma Inc.: ViroPharma&apos;s Cinryze<sup>\u00ae<\/sup> (C1 inhibitor [human]) granted European marketing authorization for hereditary angioedema (HAE) [Internet]. 2011 [cited 2017 Feb. 8]. Available from: https:\/\/www.prnewswire.com\/news-releases\/viropharmas-cinryze-c1-inhibitor-human-granted-european-marketing-authorization-for-hereditary-angioedema-hae-123912304.html"},{"key":"26","unstructured":"26. Pharmiweb.com: European Commission approves self-administration label for Firazyr<sup>\u00ae<\/sup> (icatibant) for the symptomatic treatment of acute hereditary angioedema attacks [Internet]. 2011 [cited 2017 Feb. 8]. Available from: https:\/\/www.prnewswire.com\/news-releases\/european-commission-approves-self-administration-label-for-firazyrr-icatibant-for-the-symptomatic-treatment-of-acute-hereditary-angioedema-attacks-117306118.html"},{"key":"27","unstructured":"27. Food and Drug Administration: FDA approves Firazyr to treat acute attacks of hereditary angioedema [Internet]. 2011 [cited 2017 Feb. 8]. Available from: https:\/\/www.fiercepharma.com\/pharma\/fda-approves-firazyr-to-treat-acute-attacks-of-hereditary-angioedema"},{"key":"28","unstructured":"28. CSL Behring: CSL Behring receives European Health Authorities&apos; approval of Berinert<sup>\u00ae<\/sup> for short-term prophylaxis in adults and children [Internet]. 2013 [cited 2017 Feb. 8]. Available from: https:\/\/www.prnewswire.com\/news-releases\/csl-behring-receives-european-health-authorities-approval-of-berinert-for-short-term-prophylaxis-in-adults-and-children-203186131.html"},{"key":"29","unstructured":"29. CSL Behring: CSL Behring received MHRA approval for self-administration of Berinert<sup>\u00ae<\/sup> (C1 esterase inhibitor, human) [Internet]. 2012 [cited 2017 Feb. 8]. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/7043"},{"key":"30","unstructured":"30. ViroPharma Inc.: ViroPharma receives Complete Response letter for CinryzeTM supplemental Biologics License Application for acute treatment of hereditary angioedema [Internet]. 2009 [cited 2017 Feb. 8]. Available from: http:\/\/files.shareholder.com\/downloads\/ABEA-4ZUL1I\/0x0x434585\/5891844f-9fc3-4f9b-930f-4ae179fa4e46\/VPHM_News_2009_6_4_General_Releases.pdf"},{"key":"31","unstructured":"31. Maurer M, Aberer W, Bouillet L, et al. IOS Investigators: Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment. PLoS ONE 8: e53773, 2013."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Levi M, Choi G, Picavet C, Hack CE. Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency. J Allergy Clin Immunol 117: 904-908, 2006.","DOI":"10.1016\/j.jaci.2006.01.002"},{"key":"33","unstructured":"33. Squeglia V, Barbarino A, Bova M, et al. High attack frequency in patients with angioedema due to C1-inhibitor deficiency is a major determinant in switching to home therapy: a real-life observational study. Orphanet J Rare Dis 11: 133, 2016."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Horiuchi T, Ohi H, Ohsawa I, et al. Guideline for hereditary angioedema (HAE) 2010 by the Japanese Association for Complement Research - secondary publication. Allergol Int 61: 559-562, 2012.","DOI":"10.2332\/allergolint.12-RAI-0471"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Lindoff C, Rybo G, Astedt B. Treatment with tranexamic acid during pregnancy, and the risk of thrombo-embolic complications. Thromb Haemost 70: 238-240, 1993.","DOI":"10.1055\/s-0038-1649475"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/5\/57_9407-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T11:48:53Z","timestamp":1570276133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/5\/57_9407-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9407-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}